[SARS-CoV-2 Infection and Autoimmunity]

Overview

Journal Z Rheumatol

Publisher Springer

Specialty Rheumatology

Date 2023 Dec 18

PMID 38108865

Authors

Almut Meyer-Bahlburg

Affiliations

Soon will be listed here.

Abstract

Even in the early phase of the corona pandemic in 2020, severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) was referred to as an "autoimmune virus". Since then, there have been numerous reports on the increased incidence of autoantibodies and autoimmune phenomena after SARS-CoV‑2 infections. On the one hand, autoantibodies can influence the course of the disease and on the other hand, they can lead to the first manifestation of new autoimmune diseases. In addition, a role of autoantibodies in the pathogenesis of post-coronavirus disease (post-COVID) is discussed. In the present review article, important aspects and studies are listed and the possible therapeutic consequences resulting from the findings are presented.

Citing Articles

[Rheumatology in Germany in the SARS-CoV-2 pandemic].

Huppertz H, Muller-Ladner U, Specker C Z Rheumatol. 2024; 83(7):517-519.

PMID: 39348011 DOI: 10.1007/s00393-024-01573-0.

References

Abdelwahab O, Diab R, Elsaeidy K, Albakri K, El-Samahy M, Ramadan O . Efficacy of therapeutic plasma exchange in patients with severe COVID-19: A systematic review and meta-analysis. Rev Med Virol. 2023; 33(3):e2435. DOI: 10.1002/rmv.2435. View

Acosta-Ampudia Y, Monsalve D, Rojas M, Rodriguez Y, Zapata E, Ramirez-Santana C . Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome. J Infect Dis. 2022; 225(12):2155-2162. PMC: 8903340. DOI: 10.1093/infdis/jiac017. View

Baechle C, Eckert A, Kamrath C, Neu A, Manuwald U, Thiele-Schmitz S . Incidence and presentation of new-onset type 1 diabetes in children and adolescents from Germany during the COVID-19 pandemic 2020 and 2021: Current data from the DPV Registry. Diabetes Res Clin Pract. 2023; 197:110559. DOI: 10.1016/j.diabres.2023.110559. View

Cabral-Marques O, Moll G, Catar R, Preuss B, Bankamp L, Pecher A . Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium. Autoimmun Rev. 2023; 22(5):103310. DOI: 10.1016/j.autrev.2023.103310. View

Chang R, Chen T, Wang S, Hung Y, Chen H, Wei C . Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study. EClinicalMedicine. 2023; 56:101783. PMC: 9830133. DOI: 10.1016/j.eclinm.2022.101783. View

Chang S, Feng A, Meng W, Apostolidis S, Mack E, Artandi M . New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun. 2021; 12(1):5417. PMC: 8440763. DOI: 10.1038/s41467-021-25509-3. View

Dotan A, David P, Arnheim D, Shoenfeld Y . The autonomic aspects of the post-COVID19 syndrome. Autoimmun Rev. 2022; 21(5):103071. PMC: 8848724. DOI: 10.1016/j.autrev.2022.103071. View

Fonseca-Gonzalez G, Alamilla-Sanchez M, Garcia-Macas V, Herrera-Acevedo J, Villalobos-Brito M, Tapia-Rangel E . Impact of plasmapheresis on severe COVID-19. Sci Rep. 2023; 13(1):163. DOI: 10.1038/s41598-022-25930-8. View

Garmendia J, Garcia A, De Sanctis C, Hajduch M, De Sanctis J . Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19. Curr Issues Mol Biol. 2023; 45(1):33-50. PMC: 9857622. DOI: 10.3390/cimb45010003. View

10.

Halpert G, Shoenfeld Y . SARS-CoV-2, the autoimmune virus. Autoimmun Rev. 2020; 19(12):102695. PMC: 7598743. DOI: 10.1016/j.autrev.2020.102695. View

11.

Kamrath C, Monkemoller K, Biester T, Rohrer T, Warncke K, Hammersen J . Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany. JAMA. 2020; 324(8):801-804. PMC: 7372511. DOI: 10.1001/jama.2020.13445. View

12.

Koczulla A, Ankermann T, Behrends U, Berlit P, Berner R, Boing S . [German S1 Guideline Long-/Post-COVID]. Pneumologie. 2022; 76(12):855-907. DOI: 10.1055/a-1946-3230. View

13.

Loske J, Rohmel J, Lukassen S, Stricker S, Magalhaes V, Liebig J . Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat Biotechnol. 2021; 40(3):319-324. DOI: 10.1038/s41587-021-01037-9. View

14.

Salmi H, Heinonen S, Hastbacka J, Laaperi M, Rautiainen P, Miettinen P . New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic. Arch Dis Child. 2021; 107(2):180-185. DOI: 10.1136/archdischild-2020-321220. View

15.

Scheibenbogen C, Loebel M, Freitag H, Krueger A, Bauer S, Antelmann M . Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME. PLoS One. 2018; 13(3):e0193672. PMC: 5854315. DOI: 10.1371/journal.pone.0193672. View

16.

Sher E, Cosovic A, Dzidic-Krivic A, Karahmet Farhat E, Pinjic E, Sher F . Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases. Life Sci. 2023; 319:121531. PMC: 9969758. DOI: 10.1016/j.lfs.2023.121531. View

17.

Sotzny F, Filgueiras I, Kedor C, Freitag H, Wittke K, Bauer S . Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity. Front Immunol. 2022; 13:981532. PMC: 9552223. DOI: 10.3389/fimmu.2022.981532. View

18.

Steels S, Van Elslande J, De Munter P, Bossuyt X . Transient Increase of Pre-existing Anti-IFN-α2 Antibodies Induced by SARS-CoV-2 Infection. J Clin Immunol. 2022; 42(4):742-745. PMC: 8926884. DOI: 10.1007/s10875-022-01235-3. View

19.

Unsworth R, Wallace S, Oliver N, Yeung S, Kshirsagar A, Naidu H . New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K. Diabetes Care. 2020; 43(11):e170-e171. DOI: 10.2337/dc20-1551. View

20.

Wang E, Mao T, Klein J, Dai Y, Huck J, Jaycox J . Diverse functional autoantibodies in patients with COVID-19. Nature. 2021; 595(7866):283-288. DOI: 10.1038/s41586-021-03631-y. View